The coaching access is a plus, and the variety of dosage forms gives patients options
Peptide shots for weight loss go subcutaneous, just under the skin, bypassing digestion entirely
Specific triggers for medical consultation include achieving less than 5% body weight reduction after reaching the maintenance dose (for Wegovy, after 12 weeks at 2.4 mg as per FDA labeling), prolonged weight loss plateau despite adherence, or intolerable side effects preventing dose escalation to therapeutic levels
Results showed that people on Medicaid or Medicare, Black patients and those experiencing nausea or other GI side effects were more likely to quit their GLP-1 drug
And were now also testing it out in Alzheimers disease, where we hope we can show in data end of next year that being on this medicine can bring benefit for people with Alzheimers disease
This just made it feel manageable Ana, US on getting started Got my dad using it too